Skip to main content
Top
Published in: BMC Pulmonary Medicine 1/2024

Open Access 01-12-2024 | Lung Cancer | Research

Distribution and characteristics of malignant tumours by lung lobe

Authors: Yngvar Nilssen, Odd Terje Brustugun, Lars Fjellbirkeland, Åslaug Helland, Bjørn Møller, Sissel Gyrid Freim Wahl, Steinar Solberg

Published in: BMC Pulmonary Medicine | Issue 1/2024

Login to get access

Abstract

Background

The main focus on the characteristics of malignant lung tumours has been the size, position within the lobe, and infiltration into neighbouring structures. The aim of this study was to investigate the distribution and characteristics of malignant tumours between the lung lobes and whether the diagnosis, treatment, and outcome differed based on location.

Methods

This study is based on 10,849 lung cancer patients diagnosed in 2018–2022 with complete data on the location and characteristics of the tumours. The proportions of tumours in each lobe divided by its volume were termed the relative proportion.

Results

The right upper lobe comprised 31.2% of the tumours and 17.6% of the lung volume. The relative proportion of 1.77 was higher than in the other lobes (p < 0.001). The right middle lobe had a relative proportion of 0.64 but the highest proportion of neuroendocrine tumours (26.1% vs. 15.3 on average). Surgical resection was more often performed in patients with tumours in the lower lobes, and curative radiotherapy was more often performed in the upper lobes. After adjusting for age, sex, stage, and histology, the location of the tumour was found to be a significant independent predictor for resection but not for survival.

Conclusion

The main finding of the right upper lobe as a site of predilection for lung cancer is similar to tuberculosis and pneumoconiosis. This may be explained that most of the inhaled air, containing bacilli, inorganic particles or tobacco smoke goes to the upper and right parts of the lung.
Appendix
Available only for authorised users
Literature
1.
go back to reference Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage groupings in the Forthcoming (Eighth) Edition of the TNM classification for Lung Cancer. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2016;11(1):39–51.CrossRef Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM Stage groupings in the Forthcoming (Eighth) Edition of the TNM classification for Lung Cancer. J Thorac Oncology: Official Publication Int Association Study Lung Cancer. 2016;11(1):39–51.CrossRef
2.
go back to reference Gu K, Lee HY, Lee K, Choi JY, Woo SY, Sohn I, Kim HK, Choi YS, Kim J, Zo JI, et al. Integrated evaluation of clinical, pathological and radiological prognostic factors in squamous cell carcinoma of the lung. PLoS ONE. 2019;14(10):e0223298.CrossRefPubMedPubMedCentral Gu K, Lee HY, Lee K, Choi JY, Woo SY, Sohn I, Kim HK, Choi YS, Kim J, Zo JI, et al. Integrated evaluation of clinical, pathological and radiological prognostic factors in squamous cell carcinoma of the lung. PLoS ONE. 2019;14(10):e0223298.CrossRefPubMedPubMedCentral
3.
go back to reference Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, Watanabe Y, Mitsudomi T, Yoshimura M, Tsuboi M. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg. 2001;122(4):803–8.CrossRefPubMed Ichinose Y, Kato H, Koike T, Tsuchiya R, Fujisawa T, Shimizu N, Watanabe Y, Mitsudomi T, Yoshimura M, Tsuboi M. Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg. 2001;122(4):803–8.CrossRefPubMed
4.
go back to reference Strand TE, Rostad H, Møller B, Norstein J. Survival after resection for primary lung cancer: a population based study of 3211 resected patients. Thorax. 2006;61(8):710–5.CrossRefPubMedPubMedCentral Strand TE, Rostad H, Møller B, Norstein J. Survival after resection for primary lung cancer: a population based study of 3211 resected patients. Thorax. 2006;61(8):710–5.CrossRefPubMedPubMedCentral
5.
go back to reference Shaverdian N, Veruttipong D, Wang J, Kupelian P, Steinberg M, Lee P. Location matters: stage I non-small-cell carcinomas of the lower lobes treated with stereotactic body Radiation Therapy are Associated with Poor outcomes. Clin Lung Cancer. 2017;18(2):e137–42.CrossRefPubMed Shaverdian N, Veruttipong D, Wang J, Kupelian P, Steinberg M, Lee P. Location matters: stage I non-small-cell carcinomas of the lower lobes treated with stereotactic body Radiation Therapy are Associated with Poor outcomes. Clin Lung Cancer. 2017;18(2):e137–42.CrossRefPubMed
6.
go back to reference Tamura M, Matsumoto I, Tanaka Y, Saito D, Yoshida S, Takata M, Takemura H. Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer. Gen Thorac Cardiovasc Surg. 2020;68(3):261–5.CrossRefPubMed Tamura M, Matsumoto I, Tanaka Y, Saito D, Yoshida S, Takata M, Takemura H. Prognostic factor and treatment strategy for clinical N1 non-small cell lung cancer. Gen Thorac Cardiovasc Surg. 2020;68(3):261–5.CrossRefPubMed
7.
go back to reference Tseng CH, Chen KC, Hsu KH, Tseng JS, Ho CC, Hsia TC, Su KY, Wu MF, Chiu KL, Liu CM, et al. EGFR mutation and lobar location of lung adenocarcinoma. Carcinogenesis. 2016;37(2):157–62.CrossRefPubMed Tseng CH, Chen KC, Hsu KH, Tseng JS, Ho CC, Hsia TC, Su KY, Wu MF, Chiu KL, Liu CM, et al. EGFR mutation and lobar location of lung adenocarcinoma. Carcinogenesis. 2016;37(2):157–62.CrossRefPubMed
8.
go back to reference Lee HW, Lee CH, Park YS. Location of stage I-III non-small cell lung cancer and survival rate: systematic review and meta-analysis. Thorac cancer. 2018;9(12):1614–22.CrossRefPubMedPubMedCentral Lee HW, Lee CH, Park YS. Location of stage I-III non-small cell lung cancer and survival rate: systematic review and meta-analysis. Thorac cancer. 2018;9(12):1614–22.CrossRefPubMedPubMedCentral
9.
go back to reference Lee HW, Park YS, Park S, Lee CH. Poor prognosis of NSCLC located in lower lobe is partly mediated by lower frequency of EGFR mutations. Sci Rep. 2020;10(1):14933.CrossRefPubMedPubMedCentral Lee HW, Park YS, Park S, Lee CH. Poor prognosis of NSCLC located in lower lobe is partly mediated by lower frequency of EGFR mutations. Sci Rep. 2020;10(1):14933.CrossRefPubMedPubMedCentral
10.
go back to reference da Cunha Santos G, Shepherd FA, Tsao MS. EGFR mutations and lung cancer. Annu Rev Pathol. 2011;6:49–69.CrossRefPubMed da Cunha Santos G, Shepherd FA, Tsao MS. EGFR mutations and lung cancer. Annu Rev Pathol. 2011;6:49–69.CrossRefPubMed
11.
go back to reference Bergan F. The investigation of the relative function of the right and left lung by broncho-spirometry. Technique, physiology and application. New York / London: Grune & Stratton Inc; 1957. Bergan F. The investigation of the relative function of the right and left lung by broncho-spirometry. Technique, physiology and application. New York / London: Grune & Stratton Inc; 1957.
12.
go back to reference Yamada Y, Yamada M, Yokoyama Y, Tanabe A, Matsuoka S, Niijima Y, Narita K, Nakahara T, Murata M, Fukunaga K, et al. Differences in lung and lobe volumes between Supine and Standing positions scanned with conventional and newly developed 320-Detector-row upright CT: intra-individual comparison. Respiration. 2020;99(7):598–605.CrossRefPubMed Yamada Y, Yamada M, Yokoyama Y, Tanabe A, Matsuoka S, Niijima Y, Narita K, Nakahara T, Murata M, Fukunaga K, et al. Differences in lung and lobe volumes between Supine and Standing positions scanned with conventional and newly developed 320-Detector-row upright CT: intra-individual comparison. Respiration. 2020;99(7):598–605.CrossRefPubMed
13.
go back to reference Corryn B, Nicholoson A. Pathology Og the lungs. 3rd ed. Churchill Livingston Elsevier; 2011. Corryn B, Nicholoson A. Pathology Og the lungs. 3rd ed. Churchill Livingston Elsevier; 2011.
14.
go back to reference Larsen IK, Småstuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Møller B. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218–31.CrossRefPubMed Larsen IK, Småstuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, Møller B. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer. 2009;45(7):1218–31.CrossRefPubMed
17.
go back to reference White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–99.MathSciNetCrossRefPubMed White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011;30(4):377–99.MathSciNetCrossRefPubMed
18.
go back to reference Dickman PW, Coviello E. Estimating and modeling relative survival. Stata J. 2015;15:186–215.CrossRef Dickman PW, Coviello E. Estimating and modeling relative survival. Stata J. 2015;15:186–215.CrossRef
20.
go back to reference Coviello E, Dickman PW, Seppä K, Pokhrel A. Estimating ne surviving using life-table approach. Stata J. 2015;15:173–85.CrossRef Coviello E, Dickman PW, Seppä K, Pokhrel A. Estimating ne surviving using life-table approach. Stata J. 2015;15:173–85.CrossRef
21.
go back to reference Liavaag K. Bronchiogenic Carcinoma. Acta Chir Scand. 1949;98:182–204. Liavaag K. Bronchiogenic Carcinoma. Acta Chir Scand. 1949;98:182–204.
22.
go back to reference Hill W, Lim EL, Weeden CE, Lee C, Augustine M, Chen K, Kuan FC, Marongiu F, Evans EJ Jr., Moore DA, et al. Lung adenocarcinoma promotion by air pollutants. Nature. 2023;616(7955):159–67.CrossRefADSPubMedPubMedCentral Hill W, Lim EL, Weeden CE, Lee C, Augustine M, Chen K, Kuan FC, Marongiu F, Evans EJ Jr., Moore DA, et al. Lung adenocarcinoma promotion by air pollutants. Nature. 2023;616(7955):159–67.CrossRefADSPubMedPubMedCentral
23.
go back to reference Sagerup CM, Småstuen M, Johannesen TB, Helland Å, Brustugun OT. Sex-specific trends in lung cancer incidence and survival: a population study of 40,118 cases. Thorax. 2011;66(4):301–7.CrossRefPubMed Sagerup CM, Småstuen M, Johannesen TB, Helland Å, Brustugun OT. Sex-specific trends in lung cancer incidence and survival: a population study of 40,118 cases. Thorax. 2011;66(4):301–7.CrossRefPubMed
25.
go back to reference Holst J, Semb C, Frimann-Dahl J. On the surgical treatment of pulmonary tuberculosis. Nathionaltrykkeriet, Oslo; 1935. Holst J, Semb C, Frimann-Dahl J. On the surgical treatment of pulmonary tuberculosis. Nathionaltrykkeriet, Oslo; 1935.
26.
go back to reference Kumar V, Abbas A, Fausto N, Mitchell R. Robbins Basic Pathology. Philadelphia, PA: Saunders Elsevier; 2007. Kumar V, Abbas A, Fausto N, Mitchell R. Robbins Basic Pathology. Philadelphia, PA: Saunders Elsevier; 2007.
28.
go back to reference Semb C. Surgical treatment of pulmonary tuberculosis. Acta Chir Scand. 1962;124:213–28.PubMed Semb C. Surgical treatment of pulmonary tuberculosis. Acta Chir Scand. 1962;124:213–28.PubMed
29.
go back to reference Kumar. V, Abbas. A. J A: Robbins Basic Pathology. 10th ed. Elsevier; 2017. Kumar. V, Abbas. A. J A: Robbins Basic Pathology. 10th ed. Elsevier; 2017.
30.
go back to reference Milic-Emili J, Henderson JA, Dolovich MB, Trop D, Kaneko K. Regional distribution of inspired gas in the lung. J Appl Physiol. 1966;21(3):749–59.CrossRefPubMed Milic-Emili J, Henderson JA, Dolovich MB, Trop D, Kaneko K. Regional distribution of inspired gas in the lung. J Appl Physiol. 1966;21(3):749–59.CrossRefPubMed
31.
go back to reference Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, Olsson A, Ahrens W, Gross IM, Brüske I, et al. Cigarette smoking and lung cancer–relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012;131(5):1210–9.CrossRefPubMed Pesch B, Kendzia B, Gustavsson P, Jöckel KH, Johnen G, Pohlabeln H, Olsson A, Ahrens W, Gross IM, Brüske I, et al. Cigarette smoking and lung cancer–relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer. 2012;131(5):1210–9.CrossRefPubMed
Metadata
Title
Distribution and characteristics of malignant tumours by lung lobe
Authors
Yngvar Nilssen
Odd Terje Brustugun
Lars Fjellbirkeland
Åslaug Helland
Bjørn Møller
Sissel Gyrid Freim Wahl
Steinar Solberg
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Pulmonary Medicine / Issue 1/2024
Electronic ISSN: 1471-2466
DOI
https://doi.org/10.1186/s12890-024-02918-w

Other articles of this Issue 1/2024

BMC Pulmonary Medicine 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine